Peter Mesenbrink

Once-Yearly Zoledronic Acid for Treatment of Postmenopausal Osteoporosis

Dennis M. Black, Pierre D. Delmas, Richard Eastell et al. · New England Journal of Medicine · 2007 · 2.9K citations · Full text

Zoledronic Acid and Clinical Fractures and Mortality after Hip Fracture

Kenneth W. Lyles, Cathleen Colón‐Emeric, Jay Magaziner et al. · New England Journal of Medicine · 2007 · 2K citations · Full text

Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial

David M. Reid, Jean‐Pierre Devogelaer, Kenneth G. Saag et al. · The Lancet · 2009 · 525 citations · Full text

Bone Disease, Zoledronic Acid, Bone Health +5

Comparison of a Single Infusion of Zoledronic Acid with Risedronate for Paget's Disease

Ian R. Reid, Paul D. Miller, Kenneth W. Lyles et al. · New England Journal of Medicine · 2005 · 429 citations · Full text

Characterization of and Risk Factors for the Acute-Phase Response after Zoledronic Acid

Ian R. Reid, Greg Gamble, Peter Mesenbrink et al. · The Journal of Clinical Endocrinology & Metabolism · 2010 · 244 citations · Full text